|
(Health-NewsWire.Net, November 16, 2021 ) The infection surveillance solutions market is projected to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%.
The growth of this market is influenced primarily due to the increasing incidence of hospital-acquired infections (HAIs) and new Medicare policies, including non-payment for hospital-acquired conditions. The rising healthcare expenditure, increasing number of surgeries, growing geriatric population, and the increasing incidence of chronic diseases are the other factors driving the growth of this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517
The software segment is accounted for the largest share of the infection surveillance solutions market in 2020
Based on product, the infection surveillance solutions market is segmented into infection surveillance software solutions and infection surveillance services. In 2020, the infection surveillance software segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the increasing need for preventing HAIs and the growing number of surgical procedures
The on-premise software segment accounted for the largest share of the infection surveillance solutions market in 2020
Based on type, the infection surveillance software market is segmented into on-premise and web-based software. In 2020, the on-premise software segment accounted for the largest share of the infection surveillance software market. The large share of this segment is mainly attributed to the need for maintaining access to healthcare IT solutions and reduce the risk of data breaches & external attacks.
The product support and maintenance services segment accounted for the largest share of the infection surveillance solutions market in 2020
Based on type, the infection surveillance services market is segmented into product support and maintenance services, training and consulting services, and implementation services. In 2020, the product support and maintenance services segment accounted for the largest share of the infection surveillance services market. Product support and maintenance services take care of interoperability and software complexity issues. These services ensure that clients (healthcare providers) obtain access to the vendor company’s technical knowledge base, gain support from its product support team, and acquire application management skills. These factors are driving the growth of the product support and maintenance services segment.
The hospitals segment accounted for the largest share of the infection surveillance solutions market in 2020
Based on end user, the infection surveillance solutions market is segmented into hospitals, long-term care facilities, and other end users. In 2020, the hospitals segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the large patient volume, the increasing incidence of HAIs, and the increasing cases of SSIs. The COVID-19 pandemic has also increased the adoption of infection surveillance solutions in hospitals.
North America accounted for the largest share of the infection surveillance solutions market in 2020
In 2020, North America accounted for the largest share of the infection surveillance solutions market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this region can be attributed to factors such as the growing consolidation among healthcare providers, widespread adoption of healthcare IT solutions to curtail the rising healthcare costs, increasing incidence of HAIs, and the rising number of COVID-19 patients in the US. The presence of a large number of players in the region is also a key factor contributing to the large share of North America in the infection surveillance solutions market.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21857517
Key Market Players
The prominent players in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and Vizzia Technologies (US).
Recent Developments
- In 2021, IBM Corporation (US) acquired BoxBoat (US). With this acquisition, BoxBoat will extend IBM's container strategy and implementation services portfolio to further advance IBM's hybrid cloud strategy.
- In 2021, bioMérieux SA(France) launched EPISEQ SARS-CoV-2, a cloud-based surveillance software application intended to identify variants using samples from positive patients. Automatically updated each week, the platform identifies variants based on international nomenclatures, including any new variant of concern (VOC) as defined by the World Health Organization and the US Centers for Disease Control and Prevention.
-In 2020, Wolters Kluwer(Netherlands) enhanced its infection surveillance software Sentri 7 with AI, to identify patients at risk for Clostridioides difficile (C. diff) infection.
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
